HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Androstenetriol immunomodulation improves survival in a severe trauma hemorrhage shock model.

AbstractBACKGROUND:
Traumatic shock activates the hypothalamic-pituitary-adrenal axis (HPA) to mediate a cascade of defensive mechanisms that often include overwhelming inflammatory response and immunosuppression, which may lead to multiple organ failure. Androstenetriol (5 androstene, 3beta, 7beta, 17beta triol-AET) is a metabolite of dehydroepiandrosterone that markedly up regulates host immune response, prevents immune suppression, modulates inflammation and improves survival after lethal infections by pathogens and lethal radiation.
HYPOTHESIS:
AET-induced immune modulation will improve survival in a conscious rodent model of traumatic shock.
METHODS:
A relevant traumatic shock rodent model that applies to both combat and civilian sectors was used. After creation of a midline laparotomy (soft tissue trauma), animals were hemorrhaged to a mean arterial pressure of 35-40 mm Hg. Resuscitation was initiated sixty minutes later with crystalloid fluid and packed red blood cells and animals were observed for two days. In a randomized and blinded fashion, AET or vehicle was administered subcutaneously at the beginning of resuscitation.
RESULTS:
In the vehicle group 5 out of 16 animals survived, (31%). In contrast, 9 out of 13 animals who received AET survived (69%), (Fisher Exact Test p < 0.05). Survival in the AET treatment group was associated with reduced levels of IL-6, IL-10, and IL-18, and enhanced IFN-gamma and IL-2 levels.
CONCLUSION:
: The results indicate that AET provides a significant protective effect and improves survival in a clinically relevant model of traumatic hemorrhagic shock. AET protective effects are associated with an elevation of Th1 and reduction of Th2 cytokines.
AuthorsAndreea C Marcu, Kristin E Paccione, R Wayne Barbee, Robert F Diegelmann, Rao R Ivatury, Kevin R Ward, Roger M Loria
JournalThe Journal of trauma (J Trauma) Vol. 63 Issue 3 Pg. 662-9 (Sep 2007) ISSN: 1529-8809 [Electronic] United States
PMID18073617 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • 5-androstene-3,7,17-triol
  • Androstenols
  • Immunologic Factors
  • Interleukin-6
  • Interleukin-8
  • Interleukin-10
Topics
  • Androstenols (pharmacology)
  • Animals
  • Disease Models, Animal
  • Immunologic Factors (pharmacology)
  • Interleukin-10 (blood)
  • Interleukin-6 (blood)
  • Interleukin-8 (blood)
  • Male
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Resuscitation
  • Shock, Traumatic (drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: